ACADIA Pharmaceuticals Inc.
Nasdaq ACAD · San Diego, CA
Works in Cardiovascular · Genetic & rare · Neurology · Ophthalmology · Psychiatry
ACADIA Pharmaceuticals Inc. is a clinical trial sponsor based in San Diego, CA, listed as Nasdaq ACAD. It has 5 active clinical trials with 2,285 planned participants, across 5 therapeutic areas. Since 2021 it has completed 12 trials and stopped 9 early.
Trial track record · since 2021
Financials · Nasdaq ACAD
Pipeline · 5 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
4 approved drug applications with a product on the market.
Questions about ACADIA Pharmaceuticals Inc
ACADIA Pharmaceuticals Inc is lead sponsor of 5 active clinical trials on ClinicalTrials.gov, with 2,285 planned participants, in Cardiovascular, Genetic & rare, Neurology, Ophthalmology and other areas. Since 2021 it has completed 12 trials and stopped 9 early.
ACADIA Pharmaceuticals Inc is based in San Diego, CA and is listed as Nasdaq ACAD. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with ACADIA Pharmaceuticals Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-15.
Approve Suite is not affiliated with ACADIA Pharmaceuticals Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.